Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation

Journal of Surgical Research

Volumn 96, Issue 2, 2001, Pages 173-182

  Howdieshell, Thomas R ^a   Callaway, Dianne ^a   Webb, Whitney L ^a   Gaines, Michael D ^a   Procter Jr , Charles D ^a   Sathyanarayana, ^a   Pollock, Jennifer S ^a   Brock, Tommy L ^b   McNeil, Paul L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b TEXAS BIOTECHNOLOGY CORPORATION   (United States)

Author keywords

Angiogenesis; Granulation tissue; Vascular endothelial growth factor; Wound healing

Indexed keywords

ANGIOGENIC FACTOR; ANTIBODY; SILICONE; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ABDOMINAL WALL; ABDOMINAL WALL HERNIA; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULATION TISSUE; HISTOLOGY; IMAGE ANALYSIS; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; SWINE; TREATMENT OUTCOME; WOUND CLOSURE; WOUND HEALING;

EID: 0035746834     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2001.6089     Document Type: Article

References (36)

1. Vascular permeability factor (VPF, VEGF) in tumor biology
2. Induction of a fibrin-gel investment: An early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products
3. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs
4. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
5. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines
6. Purification of a vascular permeability factor (VPF) from tumor cell conditioned medium
7. Human vascular permeability factor: Isolation from U937 cells
8. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor
9. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorder
10. Vascular permeability factor/endothelial growth factor (VPF/VEGF) accumulation and expression in human synovial fluids and rheumatoid synovial tissue
11. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
12. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
13. Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma
14. Healing of partial thickness porcine skin wounds in a liquid environment
15. Sathyanarayana, and McNeil, P. L. Normoxic wound fluid contains high levels of vascular endothelial growth factor
16. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing
17. Instrumentation
18. The microvascular composition of the healing wound compared at skin sites with nutritive versus arteriovenous perfusion
19. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor
20. Temporary abdominal wall closure in trauma patients: Indications, technique, and results
21. Abdominal wall reconstruction after temporary abdominal wall closure in trauma patients
22. The physiology of wound healing
23. Cutaneous wound healing
24. Role of platelet-derived growth factor in vivo
25. Modulation of wound repair by members of the fibroblast growth factor family
26. Transforming growth factor-beta
27. Control of scarring in adult wounds by neutralizing antibody to transforming growth factor beta
28. Neutralizing antibody to TGF-beta modulates stromal fibrosis but not regression of photoablative effect following PRK
29. Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor
30. Epidermal growth factor and transforming growth factor-alpha
31. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair
32. Mono-specific antibodies implicate basic fibroblast growth factor in normal wound repair
33. Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells
34. Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis
35. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
36. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells